Segment switch complete - Leonardo Venture listed in Prime Standard on the Frankfurt Securities Exchange
Geschrieben am 29-10-2007 |
-------------------------------------------------------------------------------- ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. --------------------------------------------------------------------------------
shares/Venture Capital / Private Equity / Investments
Mannheim (euro adhoc) - From today on, the shares of Leonardo Venture GmbH & Co. KGaA are listed in the Prime Standard of the Frankfurt Securities Exchange. Having been one of the first enterprises to decide on a listing in the Entry Standard in October 2005, the Company now, however, counts amongst those pioneers that have opted to switch segments into the Prime Standard. The early-stage financier last week successfully completed a capital increase. "The switch to the Prime Standard is for us a clear affirmation of our growth strategy and an investment in the future," explains Managing Director Prof. Udo Wupperfeld.
Prime Standard companies are subject to strict - internationally normal - transparency requirements, which go far beyond the scope that previously applied to Leonardo Venture. The Prime Standard is tailored to the needs of companies seeking to position themselves, especially vis-à-vis international investors, through a high level of transparency. With its switch to the Prime Standard, therefore, Leonardo Venture will be able to broaden its shareholder base significantly.
The low level of attention paid to the Entry Standard, and the limited opportunities as a result to communicate with investors, analysts and journalists, led Leonardo Venture to switch to the Prime Standard. Managing Director Prof. Hans-Georg Köglmayr has great expectations for future development: "We will be able to exploit the greater attention now paid to us. Our primary goal will be to reduce the existing valuation discount between the book value of our participations and the market capitalization of Leonardo Venture within the context of an active and open communication policy."
About Leonardo Venture GmbH & Co. KGaA
Leonardo Venture is a venture capital company focusing on enterprises in the area of healthcare and quality of life in Germany and abroad. Leonardo Venture invests its own funds directly in companies as an early-stage financier. Leonardo Venture possesses many years of expertise in development of its portfolio companies. The company is in constant contact with the portfolio businesses and helps them develop sustainably. In the past, the company has demonstrated that it is able to actively manage risks and sustainably develop its portfolio companies and thus contribute to an increase in their value. Besides realising a workable financing platform, the knowledge transfer, the strategic focus of the company and the contacts it opens up create the basis for revenue and income growth. Together with its competence network, Leonardo Venture guarantees effective venture management and rapid realisation of ambitious entrepreneurial goals. Shares of Leonardo Venture GmbH & Co. KGaA are listed in the Prime Standard of the Frankfurt securities market under the identification code L3V and ISIN DE0005878763
Disclaimer
This announcement is neither an offer to purchase nor a solicitation to make an offer to purchase shares or other securities. The offer in Germany will be made exclusively by means of and on the basis of the published prospectus. The prospectus is published on the Leonardo Venture GmbH & Co. KGaA website. Printed copies are available in Germany from the Company and quirin bank AG free of charge.
This announcement is neither an offer to purchase securities nor a solicitation to make an offer to purchase shares or other securities in the United States. Shares in Leonardo Venture GmbH & Co. KGaA (the "Shares") may not be offered or sold in the United States or to, or for the account of, any US person (as such term is defined in Regulation S of the US Securities Act of 1933 as amended (the `Securities Act´)) absent registration or an exemption from registration under the Securities Act. The Shares have not and will not be registered under the Securities Act.
end of announcement euro adhoc 29.10.2007 14:37:56 --------------------------------------------------------------------------------
ots Originaltext: Leonardo Venture GmbH & Co.KGaA Im Internet recherchierbar: http://www.presseportal.de
Further inquiry note: Peter Alex Tel: ++49 (0) 621-833 7 555 Alex@LeonardoVenture.de
Branche: Financial & Business Services ISIN: DE0005878763 WKN: 587876 Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade
Kontaktinformationen:
Leider liegen uns zu diesem Artikel keine separaten Kontaktinformationen gespeichert vor.
Am Ende der Pressemitteilung finden Sie meist die Kontaktdaten des Verfassers.
Neu! Bewerten Sie unsere Artikel in der rechten Navigationsleiste und finden
Sie außerdem den meist aufgerufenen Artikel in dieser Rubrik.
Sie suche nach weiteren Pressenachrichten?
Mehr zu diesem Thema finden Sie auf folgender Übersichtsseite. Desweiteren finden Sie dort auch Nachrichten aus anderen Genres.
http://www.bankkaufmann.com/topics.html
Weitere Informationen erhalten Sie per E-Mail unter der Adresse: info@bankkaufmann.com.
@-symbol Internet Media UG (haftungsbeschränkt)
Schulstr. 18
D-91245 Simmelsdorf
E-Mail: media(at)at-symbol.de
100909
weitere Artikel:
- Segmentwechsel perfekt - Leonardo Venture notiert im Prime Standard der Frankfurter Wertpapierbörse -------------------------------------------------------------------------------- ots.CorporateNews übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt der Mitteilung ist das Unternehmen verantwortlich. -------------------------------------------------------------------------------- Aktien/Venture Capital / Private Equity / Beteiligungskapital / Risikokapital Mannheim (euro adhoc) - Von heute an notieren die Aktien der Leonardo Venture GmbH & Co. KGaA im Prime Standard der Frankfurter Wertpapierbörse. mehr...
- Hinduja Group's Ashok Leyland and Nissan Sign Agreement for LCV Partnership Tokyo (ots/PRNewswire) - - Project investment estimated at US$ 500 million Hinduja Group flagship Ashok Leyland and Nissan Motor Co., Ltd., today signed a binding Master Co-Operation Agreement (MCA) for the formation of three joint venture companies supporting the Light Commercial Vehicle (LCV) business. The agreement was signed in Chennai today by Mr. R. Seshasayee, Managing Director of Ashok Leyland and Mr. Carlos Ghosn, President and CEO of Nissan Motor Co., Ltd. This agreement follows the signing of the Heads of Agreement mehr...
- D+S europe AG: D+S Member of the Management Board Sven Heyrowsky leaves Supervisory Board of Intershop AG -------------------------------------------------------------------------------- ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- professional career Hamburg (euro adhoc) - Hamburg. Oct. 29, 2007. Sven Heyrowsky, member of the management board of D+S europe AG (ISIN: DE0005336804), leaves the supervisory board of Intershop Communications AG, Jena. In a letter of October 29, 2007 Mr Heyrowsky gave mehr...
- D+S europe AG: D+S-Vorstandsmitglied Sven Heyrowsky verlässt Aufsichtsrat der Intershop AG -------------------------------------------------------------------------------- ots.CorporateNews übermittelt durch euro adhoc mit dem Ziel einer europaweiten Verbreitung. Für den Inhalt der Mitteilung ist das Unternehmen verantwortlich. -------------------------------------------------------------------------------- Personalia Hamburg (euro adhoc) - HAMBURG. 29.10.2007. Sven Heyrowsky, Vorstandsmitglied der D+S europe AG (ISIN: DE0005336804), verlässt den Aufsichtsrat der Intershop Communications AG, Jena. Mit Schreiben vom 29. Oktober mehr...
- Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration With Boehringer Ingelheim (Canada) Ltd. Toronto (ots/PRNewswire) - Dalton Medicinal Chemistry Partners, the Medicinal Chemistry arm of Dalton Pharma Services, announces that it has achieved a targeted milestone in its Medicinal Chemistry agreement with Boehringer Ingelheim (Canada) Ltd. The milestone achievement triggered payment of an undisclosed amount. Dalton Medicinal Chemistry Partners is utilizing their medicinal chemistry expertise to design and synthesize novel compounds against an antiviral target selected by Boehringer Ingelheim (Canada) Ltd. Peter Pekos, President of mehr...
|
|
|
Mehr zu dem Thema Finanzen
Der meistgelesene Artikel zu dem Thema:
Century Casinos wurde in Russell 2000 Index aufgenommen
durchschnittliche Punktzahl: 0 Stimmen: 0
|